DanCann Pharma A/S

DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.

Quotes for DanCann Pharma A/S

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Jeppe Krog Rasmussen

Chairperson of the Board

  • Carsten Trads

Board

  • Jeppe Krog Rasmussen
  • Christian Carlsen

News

Show More

News agencies

Show More

Analysis

Largest Owners

Name Capital % Votes % Date
JEQ Capital AB 10,42 10,42 2024-11-25
Niklas Estensson 4,20 4,20 2024-11-25
Robert Burén 4,20 4,20 2024-11-25
Alexander Schoeneck 3,83 3,83 2024-11-25
Erik Lundin 3,15 3,15 2024-11-25
Johan Alexander Kangas 2,52 2,52 2024-11-25
Nils Berg 2,52 2,52 2024-11-25
Love Carlsson 2,52 2,52 2024-11-25
Andreas Poike 2,10 2,10 2024-11-25
Jonas Hagberg med bolag 2,10 2,10 2024-11-25
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream

Annual reports, prospectus etc.